Clinical trial
Aripiprazole as Augmentation for TRD
NCT00174876 · State University of New York - Upstate Medical University, Other · Completed
Key facts
| NCT number | NCT00174876 |
|---|---|
| Title | Aripiprazole as Augmentation for TRD |
| Official title | An Open-Label Study of Aripiprazole (Abilify) as an Augmentation Agent in Patients With Treatment-Resistant Depression |
| Lead sponsor | State University of New York - Upstate Medical University, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Drug Abilify |
| Enrollment | 20 |
| Start date | Jul 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Sep 18, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: